Conservation, Psychedelic Therapy Investing, and Reciprocity
As the source region of Ayahuasca, the Amazon forest has been cited repeatedly this year in corporate boardrooms as the investment boom in psychedelic therapy continues to rise, projected to exceed $2 billion in 2021 alone. To prevent biopiracy, the UN CBD’s Nagoya Protocol and Brazil’s Genetic Heritage Management Council, require biodiversity-centric wealth creators to give back. To facilitate consent-based reciprocity with source communities, the Indigenous Medicine Conservation Fund is coming together with seed funding from the RiverStyx Foundation (a grantmaking pioneer in psychedelic therapy) and Dr. Bronner’s (a pioneer in fair trade). Informed by community-based assessments, the Fund will support traditional knowledge preservation, public health, and nature conservation in partnership with indigenous communities. Who is participating in the new fund? As a partner, what should real Allyship look like with Amazonian source communities? What is the future of Nagoya Protocol compliance? What is the future of Ayahuasca tourism and therapy? How can traditional conservationists collaborate with these religious and spiritual dimensions of the Amazon? Join us to meet Miriam Volat of the RiverStyx Foundation and learn.
Recorded November 29, 2021
References:
CGEN – Brazilian Genetic Heritage Management Council
The Investment Surgein Psychedelics for Treatment of Mental Health Conditions
More PsychedelicCompanies Going Public
Psychedelic CSR: Special Protections within Ayahuasca Tourism
Sacred Reciprocity: Supporting the Roots of the Psychedelic Movement
Uniao do VegetalSupreme Court Case
